Guidelines on the use of extracorporeal photopheresis
Robert Knobler(Medical University of Vienna), Uwe Hillen(University of Duisburg-Essen), Robert Gniadecki(University of Copenhagen), Ingrid Wolf(Medical University of Graz), Walter Reinisch(Medical University of Vienna), Chalid Assaf(Helios Klinikum Krefeld), Péter Jaksch(Medical University of Vienna), Hildegard Greinix(Medical University of Vienna), Lars E. French(University of Zurich), Anja Jung(Städtisches Klinikum Dessau), Leena Bruckner‐Tuderman(University Medical Center Freiburg), A. Bohbot(Université de Strasbourg), Michael Hertl(Philipps University of Marburg), Petr Arenberger(Charles University), Undine Lippert(Städtisches Klinikum Dessau), L. Laroche(Hôpital Avicenne), Harald Gollnick(Otto-von-Guericke-Universität Magdeburg), Margitta Worm(Freie Universität Berlin), Ulrike Just(Medical University of Vienna), Piergiacomo Calzavara‐Pinton(University of Brescia), Christian Jantschitsch(Medical University of Vienna), Peter Wolf(Medical University of Graz), Mark L. Barr(University of Southern California), Pietro Quaglino(Department of Medical Sciences), John A. Zic(Vanderbilt University), Evangelia Papadavid(National and Kapodistrian University of Athens), M. Bagot, Annamari Ranki(University of Helsinki), Gösta Berlin(Linköping University Hospital), Julia Scarisbrick(NIHR Surgical Reconstruction and Microbiology Research Centre), Johnny Ludvigsson(Linköping University), Alexander Enk(Heidelberg University), Thomas A. Luger(University of Münster), Thomas Schwarz(University Hospital Schleswig-Holstein), Wolfram Sterry(Clinical Research Center for Hair and Skin Science), C.‐D. Klemke(Heidelberg University), R Stadler(Johannes Wesling Klinikum Minden), Brigitte Dréno(Inserm), Hubert Pehamberger(Medical University of Vienna), Christos C. Zouboulis(Städtisches Klinikum Dessau)
Cited by 218
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k